TC OT 39 explained

Iupac Name:	(2S)-N-4-[(4,10-dihydro-1-methylpyrazolo[3,4-b][1,5]benzodiazepin-5(1H)-yl)carbonyl]-2-methylphenylmethyl]-2-[(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)thioxomethyl]-1-pyrrolidinecarboxamide
Width:	250
Cas Number:	479232-57-0
Atc Prefix:	none
Chemspiderid:	23249746
C:	32
H:	40
N:	8
O:	2
S:	1
Smiles:	Cc1cc(ccc1CNC(=O)N2CCC[C@H]2C(=S)N3CCCN(CC3)C)C(=O)N4Cc5cnn(c5Nc6c4cccc6)C
Stdinchi:	1S/C32H40N8O2S/c1-22-18-23(30(41)40-21-25-20-34-37(3)29(25)35-26-8-4-5-9-27(26)40)11-12-24(22)19-33-32(42)39-15-6-10-28(39)31(43)38-14-7-13-36(2)16-17-38/h4-5,8-9,11-12,18,20,28,35H,6-7,10,13-17,19,21H2,1-3H3,(H,33,42)/t28-/m0/s1
Stdinchikey:	KSNHHKZYKYNBEI-NDEPHWFRSA-N

TC OT 39 is a non-peptide partial agonist of the oxytocin and vasopressin V₂ receptors (K_i = 147 nM and >1000 nM, respectively) and antagonist of the vasopressin V_1A receptor (K_i = 330 nM).^[1]

Notes and References

Pitt GR, Batt AR, Haigh RM, Penson AM, Robson PA, Rooker DP, Tartar AL, Trim JE, Yea CM, Roe MB . Non-peptide oxytocin agonists . Bioorganic & Medicinal Chemistry Letters . 14 . 17 . 4585–4589 . September 2004 . 15357997 . 10.1016/j.bmcl.2004.04.107 .